Evaluation of S-[11C]citalopram as a radioligand for in vivo labelling of 
5-hydroxytryptamine uptake sites

Hume, S. P.; Lammertsma, A. A.; Bench, C. J.; Pike, V. W.; Pascali, C.; Cremer, J. E.; Dolan, Raymond J.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Evaluation of S-[11C]citalopram as a radioligand for in vivo labelling of 5-hydroxytryptamine uptake sites

MPS-Authors

There are no MPG-Authors in the publication available

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

RD_Evaluation_1992.pdf
(Publisher version), 463KB

Supplementary Material (public)

There is no public supplementary material available

Citation

Hume, S. P., Lammertsma, A. A., Bench, C. J., Pike, V. W., Pascali, C., Cremer, J. E., et al. (1992). Evaluation of S-[11C]citalopram as a radioligand for in vivo labelling of 5-hydroxytryptamine uptake sites. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology, 19, 851-855.

Cite as: https://hdl.handle.net/21.11116/0000-0001-A14E-2

Abstract

There is no abstract available